MAGE-A10 CAR T (c797T)

· Adaptimmune

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MAGE-A10 CAR T (c797T), covering 2026-02-04 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers [Phase 1]